News & Events
Knome Makes Genomic Interpretation Accessible to Startups by Sponsoring LabCentral
CAMBRIDGE, Mass. – September 9, 2014 – Knome, Inc. today announced that it has entered a sponsorship agreement with LabCentral to provide the knoSYS® Informatics and Genomic Interpretation System to startups operating in LabCentral’s facility in Kendall Square....
Webinar: Interpreting Human Next-Gen Sequencing Data with the knoSYS® Platform
Presenter: Ben Salisbury, PhD, SVP of Clinical Products at KnomeDate: August 14, 2014 AbstractEvery week a major new genomic initiative is announced that will revolutionize healthcare. Advances in sequencing technologies catalyzing these efforts are well documented....
Knome Participates in MassTLC Life Sciences Roundtable
Knome was recently honored to participate in MassTLC’s Big Data & Life Sciences roundtable. According to the report: MassTLC convened a Big Data Life Sciences roundtable, held on November 7, 2013, which included representatives from pharma, biotech, personalized...
Knome Appoints Hugh Y. Rienhoff, Jr., MD to Scientific Advisory Board
Dr. Rienhoff brings deep industry and technical expertise as Knome continues to expand CAMBRIDGE, MA – April 3, 2012 – Knome, Inc., the human genome interpretation company, today announced that it has continued to expand its scientific advisory board to include...
Webinar: Toward Precision Medicine in Neurological Disease
Presenter: David B. Goldstein, PhD, Director of the Center for Human Genome Variation at Duke University Date: November 13, 2014 Abstract One primary challenge in the interpretation of large-scale sequencing studies is the huge number of candidate variants that...
Behind the knoSYS 100: Building the Genome Supercomputer
The knoSYS® platform k100 model is featured in Bio-IT World as the “Genome Supercomputer.” An excerpt: In a clinical setting, processing and comparing large numbers of genomes is not as important as speed, confidentiality, data protection, and the ability to organize...
Knome Launches the knoSYS™ 25 Human Genome Interpretation Platform
CAMBRIDGE, MA – March 26, 2014 – Knome, Inc. announced the launch of a new addition to the knoSYS human genome interpretation platform product line. Debuting today at the annual meeting of the American College of Medical Genetics and Genomics in Nashville, Tennessee,...
Knome Launches Major Upgrade to Its Genomic Interpretation Platform, Targets Clinical and Translational Laboratories
Version 3 of the knoSYS® Platform lowers barriers to next-generation sequencing genomic testing through scalability, automation, performance, and collaboration. CAMBRIDGE, MA – August 12, 2014 – Knome, Inc. today announced the launch of the third generation of its...
Webinar: Supporting Genomics in the Practice of Medicine
Presenter: Heidi Rehm, PhD, FACMG, Chief Laboratory Director of the Laboratory for Molecular Medicine at Partners Healthcare Date: June 19, 2014 In this webinar, Dr. Heidi Rehm, Chief Laboratory Director of the Laboratory for Molecular Medicine at Partners Healthcare...
Knome and Personal Genomics to Form Sales Alliance and Scientific Partnership
CAMBRIDGE, MA, USA, April 11, 2014 – Knome, Inc. and Personal Genomics, s.r.l., Verona, Italy, announced an exclusive sales alliance for Knome’s knoSYS™ platform in Italy and a scientific partnership for continued development of the platform’s tools, content, and...